Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Bottom line is that an institutional investor, Triton, is expecting that the stock will go up.
Triton has not “held” stock in any of the other tickers they have done this with.
Huh? Triton displays a whole page of their investments including, drum roll, TSOI.
If they were in the business of flipping stocks per S-1's, doubtful that they would devote a page, which implies serious belief in their investments.
by TimGDixon » Thu Jul 02, 2020 7:22 pm
We will now hit 12,000 media outlets and 4,000 financial and biotech websites nationwide and a whole bunch of other bells and whistles i don't even understand smile Point i want to make is we are kicking everything up a notch.
So even though the 13G clearly states shares beneficially owned: 3,045,297, the 1,245,297 shares are an accounting thing; shares that could have been converted. Even for accounting, that's about as smoke & mirrors as it gets.
Nope, a/o yesterday, May 7th filing, Puritan owns 3,045,297 shares of TLSS. Hmmm, institutional investor knows something's in the works?
Really? No 13D/G’s have been filed nor will be.
Quick glance. Here's two recent institutional acquisitions.
13G - Ownership Acquisition Statement - Citadel Securities LLC Sheesh, CDEL.
13G/A - Ownership Acquisition Statement - Puritan Partners LLC
TenKay, you can probably help with this question.
True, "Most “institutional” investors are prohibited from holding ANY OTC stock...whether QB or not."
However, loosely regulated hedge funds have no such restrictions.
Some OTC observers say, There's more to be made by short-selling penny stocks than by buying and holding them.
True? Not true?
All together now ... Singing DESPERADO ...
Ahhhhh, groan, nobody selling?
TSOI = TOTAL POS JUNK STOCK!!!! DUMP IT!!!
Good overview.
Thnx for the link.
https://microcapdaily.com/the-inside-scoop-on-transportation-and-logistics-systems-inc-otcmkts-tlss/126247/
The Inside Scoop on Transportation and Logistics Systems Inc (OTCMKTS: TLSS)
Disclosure: we hold no position in TLSS either long or short and we have not been compensated for this article.
John's email.
John Mercadante, TLSS, Chairman/President/CEO
info@tlss-inc.com
Appreciated his reply via that email address.
Yes they can like bandidos with 666 tattoos.
... allowed to participate in the mkt as any retail buyer does.
https://www.otcmarkets.com/learn/market-101/regulation
However, broker-dealers supposedly "cannot use their knowledge of customer orders to make money for their own accounts without satisfying the customer's order."
Whew, not the German exchanges. That's a site in German for U.S. issues.
https://www.wallstreet-online.de/aktien/transportation-and-logistics-systems-aktie#t:1d||s:lines||a:abs||v:minute||ads:null
Frankfort?
Are you saying that TLSS is traded on Frankfurt/Xetra? ISIN or symbol?
There Frankfort is open...
Last I heard was .075.
Wrong x 2.
That's wrong and wrong.
The company stated the 26th ...
... Company anticipates filing the Annual Report with the SEC on or before June 29, 2020.
... saying things about Walmart, or NASDAQ, or $1 should be reported as well.
You wanna indict the CEO? Well, technically you're right. He's talking Walmart+, not Walmart.
Walmart+ ... Email from John Mercadante, Chairman/President/CEO
Gentlemen, any thoughts, possibilities, talks with Walmart+? Thank you.
Thank you very much for sending that along we are already in the process thank you John M
https://www.vox.com/platform/amp/recode/2020/2/27/21154357/walmart-plus-walmart-grocery-delivery-unlimited-membership-amazon-prime
Walmart is quietly working on an Amazon Prime competitor called Walmart+
Amazon Prime has devastated traditional retail. Walmart is about to fight back.
The only thing that scares the bejesus out of the manips - shorts, market makers - is huge, sudden buying volume. Negative posts devoid of perspective apparently are cheap insurance for those who could care less about establishing a reasoned, fair market value. And if those posts can cause panic selling, even driving a company into BK, the shorts NEVER have to cover. Whoohoo, free money.
Then again, some companies fight back.
Ideanomics Statement Regarding Short-Selling Activities
TLSS long
All of your points are arguable. Company is healing its financials, jumping through some painful hoops, but I still think TLSS is NASDAQ bound. How many privately held logistics companies are there that may be wondering how to go public in this important, growing industry?
Pian0wire, that's an intriguing statement. Can't let that one go.
growing the footprint of this company in a big way.
Implies TLSS isn't for sale, doesn't WANT to be acquired. Merger? Or buying Hertz for pennies on the dollar? Stranger things have happened.
Yep, agree that AV's would be a too-radical shift in the near term, but I was mostly referring to the mindset of a huge, enormously wealthy, maybe over-confident company focusing on the newest technology. However, reality should be a wake-up call. Little strange, though, that Amazon could get its panties in a bunch about something so important as last-mile (and other) logistics. Full confidence in Merc, CEO.
iHubSchlub, excellent post. Do you think Amazon's focus on autonomous vehicles; e.g. Zoox, 1.2B, is influencing, maybe even clouding its future delivery contracts? I've seen companies get so enamored with the latest, sexiest technology that they stumble repeatedly. However, makes ya wonder about the possibility of TLSS leasing AVs, as they're now called. Makes ya also wonder about the mother duck and her flock trying to cross the road.
In 2018, Bezos’ company spent $27 billion on worldwide shipping, in addition to extending its own fleet of planes, oceanic vessels, trucks, and unmanned rovers.
Possible technological obstacles for automated cars are (long list):
Artificial Intelligence is still not able to function properly in chaotic inner-city environments.
Yes, that was John's answer.
Ja, das war Johns Antwort. (I don't speak German, but fun trying.)
Walmart+ ... Email from John Mercadante, Chairman/President/CEO
Gentlemen, any thoughts, possibilities, talks with Walmart+? Thank you.
Thank you very much for sending that along we are already in the process thank you John M
https://www.vox.com/platform/amp/recode/2020/2/27/21154357/walmart-plus-walmart-grocery-delivery-unlimited-membership-amazon-prime
Walmart is quietly working on an Amazon Prime competitor called Walmart+
Amazon Prime has devastated traditional retail. Walmart is about to fight back.
TSOI MUST be attacking it with the usual rigorous steps.
https://nymag.com/intelligencer/2020/06/a-flu-strain-with-pandemic-potential-was-found-in-china.html
A Flu Strain With ‘Pandemic Potential’ Has Been Found in Pigs in China
The scientific method has five basic steps, plus one feedback step:
Make an observation.
Ask a question.
Form a hypothesis, or testable explanation.
Make a prediction based on the hypothesis.
Test the prediction.
Iterate: use the results to make new hypotheses or predictions.
Whoohoo, if this stuff works ,..
the world will thank TSOI.
Dual threat to Covid-19.
... appears to reduce innate immune induced inflammation in lungs while stimulating immune cells known to possess antiviral properties.
StemVacs™ can be administered without the need for matching donor to recipient, allowing for standardized manufacturing.
... originally due on or before May 15, 2020. The Company anticipates filing the Annual Report with the SEC on or before June 29, 2020.
https://www.sec.gov/Archives/edgar/data/1463208/000149315220008167/form8-k.htm
8-K
https://www.sec.gov/filergroup/announcements
EDGAR Technical Difficulties Update
The EDGAR technical issue experienced at approximately 4:30 p.m. Monday, June 29, 2020 has been resolved.
Please note, however, that filing agents may continue to experience technical problems related to their custom code. Those filing agents should send an email to EDGAR_Escalations@SEC.GOV as soon as possible to indicate what problems they are experiencing, or they may contact Filer Support at 202-551-8900 option 3 between 9 a.m. and 5:30 p.m. ET on Tuesday, June 30, 2020. Staff will work with filing agents to resolve these difficulties.
Filers impacted by technical difficulties who have received an accession number will have their filing dates automatically adjusted by the SEC (unless the submission was suspended for an unrelated reason). Impacted filers who have not received an accession number should make their filings as soon as they are able and should promptly contact Filer Support at 202-551-8900 option 3.
TSOI Q&A worth repeating. Difference between StemVacs?
TY Cents. 'Scuse the slight editing.
What is the difference between StemVacs for cancer immunotherapy and StemVacs for Covid 19?
The reply :
I was actually giving Dr. Ichim an opportunity to answer you but didn't want to keep you waiting... The big difference between the two versions of StemVacs is ...
... version one was autologous (blood is drawn from the patient and processed) and ...
... version 2 is allogeneic (universal donor).
Therefore the sources are different but the methodology remains the same.
Another difference is that with StemVacs for cancer, the vaccine is made on demand and requires about 8 days to manufacture.
Covid-19 patients don't have 8 days. StemVacs 2 is an off-the-shelf immunotherapy for covid-19. Meaning it can be manufactured in large numbers of doses and stored ready to use on demand.
I'm going to leave it there so that Tom may want to add some thought when he can find the time. He's in a different time zone right now too.
Tim
If anyone else wants to ask the TSOI Team a question, you can go to their Facebook page , and search for the way i found to contact them.
Hmmm, "different time zone" comment. Perhaps a hint of meeting with a very interested party?
supersg, wrong, as in totally WRONG.
mr Dixon has been selling shares
Insiders must report any sells or other disposition on Form 4, but then, you knew that.
Insiders have two business days following the transaction in question to report it using Form 4.
Whoa, sobering, eye-opening BBC article.
TY. If link doesn't work, search:
BBC How Covid-19 can damage the brain
22nd June 2020
Excerpts:
“If you had asked me a month ago if there was any published evidence that Sars-CoV-2 could cross the blood-brain barrier, I would have said no – but there are now many reports showing that it absolutely can,” says Stevens.
Most researchers believe the neurological effect of the virus are an indirect result of either oxygen starvation to the brain (the “happy hypoxia” exhibited by many patients), or the byproduct of the body’s inflammatory response (the famed “cytokine storm”). Both Fory and Helms believe the neurological effects are “cytokine-mediated”.
Others aren’t so certain: evidence is starting to accumulate demonstrating that the virus can actually invade the brain itself.
Let's hope ......
Therapeutic Solutions International Reports Reduction of Brain Inflammation/Depression Associated Biochemical Pathway Using QuadraMune™ in Animal Studies
Continued Basic Science Experiments Support New Patent Filing Covering Suppression of Indolamine 2,3 Deoxygenase Pathway by QuadraMune™
June 15, 2020
911 ... We'll see if this is true.
911 - press release/news is pending
CDEL is signaling 911 at .0911. He desperado
Sheesh, COVID-19 antibodies may fade in as little as 2 months.
If the small study proves correct, important solution being tested ... immune-boosting formulation QuadraMune.
"As the world grapples with the ongoing COVID-19 pandemic, a new study suggests that antibodies -- the proteins produced by the immune system that can grant protection against reinfection -- may fade in as little as two months after infection in certain people who have recovered from the virus.
The study was conducted in China and published in Nature Medicine.
Specifically, the study's authors found that people with COVID-19 who never develop symptoms may see their antibodies fade more quickly than those who tested positive for the virus and also came down with its tell-tale symptoms.
The study, though small and with limitations, provides greater insight into a topic that mystifies scientists examining this new coronavirus, SARS-CoV-2. Most people who have recovered from COVID-19 develop antibodies, but the extent and duration of that protection remains unknown."
https://www.nature.com/nm/
Nature Medicine
Really? Is OTC Markets wrong?
Cromwell Coulson, CEO of OTC Markets Group, made a presentation to the SEC’s Investor Advisory Committee:
Coulson also addressed the issue of short selling. Internet-based forums, especially anonymous forums that are used for stock manipulation, misinformation and fraudulent promotions, proclaim that short selling in small-cap securities is rampant and the cause of downward pricing pressure. The reality is that short selling in small-cap securities is generally minimal due to the high cost of borrow interest and coverage requirements. Most short selling in small companies is completed by market makers with a requirement to close out within 2 days. Coulson actually suggests that in addition to greater transparency and reporting of short selling activity, regulatory changes should be made to encourage heathy short selling and price stabilization efforts by market makers.
A/O Tue Jun-16-2020, more than $130 billion was left in the fund, known as the Paycheck Protection Program. I have full confidence in Messrs. Mercadante and Cerny in accounting for every penny received to date and, if necessary, in the future. How many microcaps ... you know the rest of the question. TLSS long.
Agree. Good marketing campaign, credible drums & trumpets on the better health, lifestyle, tech sites.
No buzz words. Immunotherapy ... FDA-Pending ... TSOI.
Therapeutic Solutions International Announces Intention to Use Clinical Stage NK Activating Cancer Immunotherapy for COVID-19
And in other news related to this critically important field ...
Gilead Sciences Buys Initial 49.9% Stake in Pionyr Immunotherapeutics
> Gilead said Pionyr is also eligible to receive up to $1.15 billion in payments on achieving certain development and regulatory milestones.
Playing with fire? Cover and cover your eyes. Kaboomage.
Dr. Franceso Marincola is another brainiac, among others, currently on the Scientific Advisory Board. Briefly. Summa cum laude from the University of Milan ... surgery training at Stanford University, California ... 500 peer-reviewed scientific papers. Dr. Marincola is considered one of the world’s leading experts in cancer immunotherapy.
Lots of juicy, head-spinning reading if you want the facts.
https://sec.report/Ticker/CDEL
X-17A-5 Annual Report 2020-02-28
Pg 11
https://sec.report/Document/0001146184-20-000006/
OTC securities are NOT marginable.
True, not for retail investors UNLESS you have a good relationship (pattern daytrader) with the broker and significant funds in your account, FINRA notwithstanding. Once, just for the heckuvit, just to see if I could do it, I tried to borrow a boatload of sub-pennies from my broker. I was one click away from doing it until the inexperienced broker decided that he better get authorization. Nope, but close.
One interesting question.
A market maker OWNS an OTC stock. Search, for ex., SEC filings:
Citadel Securities may be deemed to beneficially own ________ shares of common stock.
Can CDEL borrow its own shares and return them seconds, hours, days later?
Do you really believe that? ETF's, exchanges, etc. only?
Their proprietary trades are Exchange traded stocks.
And where does that CDEL number “borrowed/loaned” number come from? Are you referring to the transactions executed as riskless principle?
CDEL 2019 Annual Report.
Riskless? Nahhh,Securities borrowing and lending transactions are collateralized by pledging cash or securities, which typically include equity securities and are collateralized as a percentage of the fair value of the securities borrowed or loaned.
Are you sure about the OTC crap?
Non-exchange-traded equity securities
The Company’s non-exchange-traded equity securities typically represent securities that are traded in over-the-counter (“OTC”) markets. These non-exchange-traded equity securities are generally valued using market price quotations and are classified within Level 1 or Level 2 of the fair value hierarchy.
As mentioned, CDEL borrowed/loaned $2,979,000,000 worth of securities in 2019 alone. Hmmm, what percentage of that is OTC crap? Ask for a raise?
So you agree that market makers earn revenue from their proprietary trades.
But broker/dealers rarely use their proprietary trading accounts for OTC crap.
Well, lessee, CDEL borrowed/loaned $2,979,000,000 worth of securities in 2019 alone. Hmmm, what percentage of that is OTC crap?